Summary: Atlantis Health adds oncology patient engagement report

Why It Matters: The company is shifting its content focus from general conference highlights to specific oncology data. This suggests they are prioritizing the cancer treatment market and using expert-led research to prove their value to pharmaceutical clients.

What Changed:

• Replaced a general "ESPACOMP 2025" conference highlight link with a specific oncology report.
• Added a new publication titled "Evidence for Change: Driving Patient Engagement Impact and Adherence in Oncology."
• Updated the summary text to feature Dr. Kate Perry, Group Behavioral Science Director, discussing oncology findings.